Corpus Intelligence IC Memo — TEXAS HEALTH PRESBYTERIAN HOSPITAL P 2026-04-26 03:59 UTC
IC Memo — TEXAS HEALTH PRESBYTERIAN HOSPITAL P
Investment Committee Memorandum | TX | 305 beds | Grade C | EBITDA uplift $36.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

TEXAS HEALTH PRESBYTERIAN HOSPITAL P

CCN 450771 | COLLIN, TX | 305 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

TEXAS HEALTH PRESBYTERIAN HOSPITAL P is a 305-bed suburban community hospital in COLLIN, TX with $499.6M in net patient revenue and a 14.7% operating margin. The hospital serves a payer mix of 21.9% Medicare, 2.4% Medicaid, and 75.8% commercial.

Thesis: Platform Growth. Our ML models identify $36.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 14.7% to 22.0% (+736bps).

Net Revenue HCRIS$499.6M
Current EBITDA COMPUTED$73.3M
Operating Margin COMPUTED14.7%
Occupancy HCRIS85.6%
Revenue / Bed COMPUTED$1.6M
Net-to-Gross HCRIS30.9%
Distress Probability ML39.5%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
123
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 14.7% places it above the state median. Among 123 size-comparable peers (152-610 beds), the median margin is 4.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (152-610), prioritizing same-state peers. 123 hospitals in the comp set.

HospitalStateBedsRevenueMargin
TEXAS HEALTH PRESBYTERIAN HOSP (Target)TX305$499.6M14.7%
CHILDRENS MEDICAL CENTER OF DATX377$1.56B10.3%
COOK CHILDRENS MEDICAL CENTERTX423$1.51B16.5%
CHRISTUS MOTHER FRANCES HOSP-TTX518$971.6M-17.0%
MEDICAL CITY PLANOTX573$936.8M40.3%
DELL CHILDRENS MEDICAL CENTERTX262$901.9M25.5%
ST. DAVIDS MEDICAL CENTERTX525$870.9M26.4%
DOCTORS HOSPITAL AT RENAISSANCTX394$847.8M9.2%
HCA HOUSTON HEALTHCARE KINGWOOTX576$733.8M13.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $36.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$10.5M+210bp18mo
Cost to Collect4.5%2.5%$10.0M+200bp12mo
Denial Rate Reduction12.0%6.5%$9.9M+198bp12mo
A/R Days Reduction5200.0%3800.0%$6.1M+122bp9mo
Clean Claim Rate88.0%96.0%$320K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$10.5M
Cost to Collect
$10.0M
Denial Rate Reduction
$9.9M
A/R Days Reduction
$6.1M
Clean Claim Rate
$320K
Total EBITDA Uplift$36.8M
Current EBITDA$73.3M
+ RCM Uplift+$36.8M
Pro Forma EBITDA$110.1M
Current Margin14.7%
Pro Forma Margin22.0%
WC Released (1x)$19.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$112.7M$851.1M7.55x49.8%
Base (11x exit)10.0x11.0x$112.7M$972.8M8.63x53.9%
Bull Case9.0x11.0x$101.5M$1.13B11.15x62.0%
Bull (12x exit)9.0x12.0x$101.5M$1.26B12.45x65.6%
Bear Case11.0x10.0x$124.0M$630.6M5.09x38.4%
Bear (11x exit)11.0x11.0x$124.0M$734.0M5.92x42.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 123 hospitals with 152-610 beds
  • Same-state prioritization (n=124)
  • Comp margins: P25=-7.2% / P50=4.9% / P75=15.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.